Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022

We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% amo...

Full description

Saved in:
Bibliographic Details
Published in:Preventing chronic disease 2024-11, Vol.21, p.E90, Article 240229
Main Authors: Zaganjor, Ibrahim, Saelee, Ryan, Onufrak, Stephen, Miyamoto, Yoshihisa, Koyama, Alain K, Xu, Fang, Bullard, Kai McKeever, Pavkov, Meda E
Format: Article
Language:English
Subjects:
Adolescent
Adult
Adults
Aged
COVID-19
Diabetes
Diabetes Mellitus - diagnosis
Diabetes Mellitus - epidemiology
Educational attainment
Ethnicity
Female
Health Surveys
Humans
Male
Medical diagnosis
Middle Aged
Pandemics
Prediabetic State - diagnosis
Prediabetic State - epidemiology
Prevalence
Telemedicine
Telemedicine - statistics & numerical data
United States - epidemiology
Young Adult
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.
ISSN:1545-1151
1545-1151
DOI:10.5888/pcd21.240229